Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis

INTRODUCTION: The consistency of the treatment effect of galcanezumab throughout the dosing interval is examined in patients with episodic and chronic migraine. METHODS: This study was a post hoc analysis of clinical trial data from episodic (EVOLVE-1; EVOLVE-2; both 6-month duration) and chronic (R...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Adv Ther
Päätekijät: Pozo-Rosich, Patricia, Samaan, Karen H., Schwedt, Todd J., Nicholson, Robert A., Rettiganti, Mallikarjuna, Pearlman, Eric M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189981/
https://ncbi.nlm.nih.gov/pubmed/33950375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01708-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia